Who invested in Prelude Therapeutics?
Prelude Therapeutics's investors include OrbiMed, RA Capital Management and Fidelity.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$150Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From Prelude Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediDavid BonitaKelvin NeuMardi C. DierPaul FriedmanVictor Sandor
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Prelude Therapeutics's investors include OrbiMed, RA Capital Management and Fidelity.
Prelude Therapeutics has raised $150M across 2 rounds since 2019.
Prelude Therapeutics's most recent round was an Undisclosed round of $90M in Apr 2026.
Its most recent round, $90M in Apr 2026, is also its largest on record.
Prelude Therapeutics's first round on record, in Jun 2019, was backed by OrbiMed.
Prelude Therapeutics's latest named round is an Undisclosed round, in Apr 2026.
Prelude Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.